CA 19-9 and CA 125 as potential predictors of disease recurrence in resectable lung adenocarcinoma | PLOS ONE
Oncology
Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas – A retrospective tumor marker prognostic study - ScienceDirect
Tumor Markers:- Part 7 - CA 125 and CA 19-9 - Labpedia.net
Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports
Comparison between CEA, CA 19-9 and CA 72-4 in Patients with Colon Cancer
CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial - The Lancet Oncology
IVD Antibody Development Services for CA19-9 Marker - Creative Biolabs
Predictors of elevated cancer antigen 19-9 levels | Download Scientific Diagram
The clinical utility of normal range carbohydrate antigen 19-9 level as a surrogate marker in evaluating response to treatment in pancreatic cancer-a report of two cases. | Semantic Scholar
Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports
Biomarkers as Predictors of Recurrence following Curative Resection for Pancreatic Ductal Adenocarcinoma: A Review
CA 19-9 – Pancreatic Cancer Action Network
![PDF] Increased CA 19-9 level in patients without malignant disease | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/26d5394683ead29cd4fea31dc58ad39515b843a6/3-Table1-1.png "PDF] Increased CA 19-9 level in patients without malignant disease | Semantic Scholar")
PDF] Increased CA 19-9 level in patients without malignant disease | Semantic Scholar
Antibodies to a CA 19-9 Related Antigen Complex Identify SOX9 Expressing Progenitor Cells In Human Foetal Pancreas and Pancreatic Adenocarcinoma | Scientific Reports
CA19-9 - Wikipedia
CA19-9 for detecting recurrence of pancreatic cancer | Scientific Reports
The prognostic value of serum CA 19-9 for patients with advanced lung adenocarcinoma | BMC Cancer | Full Text
PDF) CA 19-9 in pancreatic cancer: Retrospective evaluation of patients with suspicion of pancreatic cancer
![PDF] Assessing Prognosis in Metastatic Pancreatic Cancer by the Serum Tumor Marker CA 19-9: Pretreatment Levels or Kinetics during Chemotherapy? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f7bb4eb6de25f6ecb9323cbef8061896f020a0da/2-Figure1-1.png "PDF] Assessing Prognosis in Metastatic Pancreatic Cancer by the Serum Tumor Marker CA 19-9: Pretreatment Levels or Kinetics during Chemotherapy? | Semantic Scholar")
PDF] Assessing Prognosis in Metastatic Pancreatic Cancer by the Serum Tumor Marker CA 19-9: Pretreatment Levels or Kinetics during Chemotherapy? | Semantic Scholar
Carbohydrate antigen 19-9 — tumor marker: Past, present, and future
Median overall survival according to CA 19-9 serum level baseline level. | Download Scientific Diagram
Prognostic Role of Carbohydrate Antigen 19 to 9 in Predicting Survival of Patients With Pancreatic Cancer: A Meta-Analysis - Yong-Ming Kang, Hao Wang, Ran Li, Gu Pan, 2021
The glycan CA19-9 promotes pancreatitis and pancreatic cancer in mice | Science
